Launch of BioLynx provides a boost for the international malaria research community
New NUS spin-off company launches at TechVenture 2011
12-Oct-2011 -
A new biotech company has been spun off from the National University of Singapore (NUS), to provide research tools, targeting the international malaria research community. BioLynx Technologies Pte Ltd (BioLynx) has been founded by two NUS faculty members: Dr Martin Lear from the NUS Department of ...
chloroquine
malaria